InspireMD, Inc. (NSPR) — Stock Valuation & Research

InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific. Key products include the CGuard carotid embolic prevention system, specifically designed for carotid artery procedures, and the MGuard Prime embolic…

NSPR key statistics

Price$0.79
Market cap$36.96M
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range0.63-2.57
Beta0.82

Explore NSPR's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.